Skip to main content
Premium Trial:

Request an Annual Quote

Chemizon Partners with, Invests in CrownBio

NEW YORK (GenomeWeb News) – The drug discovery company Chemizon has struck a strategic partnership with the clinical research company Crown Biosciences to offer a number of drug research capabilities, including proteomics and biomarker services, Chemizon said today.
 
Chemizon, which is a division of Optomagic, also said it has made an investment in CrownBio of an undisclosed amount through a private equity fund. 
 
The partnership will offer products and services in areas such as protein cloning and expression, protein purification, biomarker discovery and development, and X-ray crystallography, among others.
 
CrownBio has headquarters in Silicon Valley as well as research centers in Beijing and Indianapolis.
 
“With the cost of developing breakthrough therapeutics continuing to climb, we are poised to take advantage of the shift of high-value discovery research to Asia, by providing a state-of-the-art scientific platform to our collaborators,” Crown Biosience CEO Alex Wu said in a statement.
 
 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.